India to Nepal: Carfilzomib Export Trade Route

The India to Nepal Carfilzomib corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $25.0K USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $5.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #7 among India's top carfilzomib export destinations globally.

On the import side, key buyers of Indian carfilzomib in Nepal include EVEREST BANK LTD, EVEREST BANK LIMITED, D K M PHARMACEUTICALS PRIVATE LIMITED. EVEREST BANK LTD is the single largest importer with 3 shipments valued at $19.5K USD.

India's carfilzomib exports to Nepal are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Nepal benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NATCO PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $5.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as carfilnat vial (carfilzomib 60mg injection)(appendix4r,rodtep entryno:10112)(our reference(s) ci no:cwh-2024-013) and carfilnat inj 60mg/vial(carfilzomib inj60mg) (appendix4r, rodtep entry no:10112)(other reference(s) ci no:cwh-2024-002), suggesting that buyers in Nepal tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EVEREST BANK LTD is the largest importer with 3 shipments worth $19.5K USD — representing 78% of all carfilzomib imports from India on this route.